Downstream Process Development
Curia provides upstream process development (USP) services to optimize cell productivity in single-use bioreactors (SUB)
Our technical team has developed purification schemes for hundreds of unique proteins for pre-clinical tox material. Our platform processes are designed to maximize purity and yield, while minimizing the time between development and toxicology studies. The developed processes are tailored to meet our client’s specifications.